iAnthus Capital Holdings Inc (TSE:IAN)
:IAN
Top Page
iAnthus Capital Holdings
(IAN)
Select Model
Select Model
Rating:42Neutral
Price Target:
C$0.01
▲(0.00% Upside)
Action:ReiteratedDate:03/29/26
The score is primarily constrained by weak financial performance—persistent losses, negative equity, elevated leverage, and negative free cash flow in 2025—partly offset by recent positive operating cash flow and EBITDA improvement. Technical indicators are mixed with a bearish MACD and limited trend strength, while valuation is difficult to assess due to negative earnings and no dividend support.
Positive Factors
Vertical integration & retail footprint
Expanding retail footprint and vertically integrated operations in state-legal markets strengthens durable revenue channels and margin capture. Owning cultivation, manufacturing and retail permits the company to retain wholesale and retail margins across product lifecycles, supporting long-term scale and local market resilience.
Negative Factors
Negative equity / stressed balance sheet
Negative shareholders' equity is a material structural weakness that reduces financial flexibility and raises solvency risk. Persistent negative net worth constrains access to capital, may trigger covenants or creditor pressure, and limits the company's ability to absorb further operational setbacks long-term.
Read all positive and negative factors
Positive Factors
Negative Factors
Vertical integration & retail footprint
Expanding retail footprint and vertically integrated operations in state-legal markets strengthens durable revenue channels and margin capture. Owning cultivation, manufacturing and retail permits the company to retain wholesale and retail margins across product lifecycles, supporting long-term scale and local market resilience.
Read all positive factors
iAnthus Capital Holdings (IAN) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$34.86M
Dividend YieldN/A
Average Volume (3M)56.04K
Price to Earnings (P/E)―
Beta (1Y)-2.33
Revenue Growth-6.05%
EPS GrowthN/A
CountryCA
Employees716
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding6,972,552,000
10 Day Avg. Volume132,352
30 Day Avg. Volume56,044
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.24
Price to Sales (P/S)0.17
P/FCF Ratio-1.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
iAnthus Capital Holdings Business Overview & Revenue Model
Company Description
iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers biomass products, such as pre-rolls; cannabis infused products, including topical creams and edib...
How the Company Makes Money
iAnthus primarily makes money by selling cannabis and cannabis-derived products in state-regulated markets through its operating subsidiaries. Key revenue streams generally include: (1) retail sales at company-operated dispensaries (direct-to-cons...
iAnthus Capital Holdings Financial Statement Overview
Summary
Income Statement
23
Negative
Balance Sheet
12
Very Negative
Cash Flow
34
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 146.51M | 167.57M | 159.24M | 163.21M | 203.02M |
| Gross Profit | 47.22M | 75.11M | 63.17M | 74.43M | 111.28M |
| EBITDA | 5.04M | 21.22M | -2.59M | -369.80M | 7.89M |
| Net Income | -40.91M | -7.64M | -76.62M | -449.39M | -76.25M |
Balance Sheet | |||||
| Total Assets | 275.19M | 271.04M | 277.41M | 303.47M | 346.74M |
| Cash, Cash Equivalents and Short-Term Investments | 11.85M | 18.54M | 13.10M | 14.34M | 13.24M |
| Total Debt | 227.54M | 210.46M | 201.00M | 183.94M | 228.54M |
| Total Liabilities | 378.05M | 336.58M | 339.07M | 292.48M | 369.14M |
| Stockholders Equity | -102.85M | -65.54M | -61.67M | 10.99M | -22.40M |
Cash Flow | |||||
| Free Cash Flow | -20.99M | 7.03M | -3.06M | -26.55M | -4.25M |
| Operating Cash Flow | 3.20M | 12.54M | 3.02M | -19.50M | 16.15M |
| Investing Cash Flow | 2.34M | -6.28M | -3.63M | -4.74M | -21.32M |
| Financing Cash Flow | -12.89M | -339.00K | -618.00K | 22.06M | 10.24M |
iAnthus Capital Holdings Risk Analysis
iAnthus Capital Holdings disclosed 65 risk factors in its most recent earnings report. iAnthus Capital Holdings reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
iAnthus Capital Holdings Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | C$2.29B | 16.23 | 6.29% | ― | 6.18% | -28.69% | |
56 Neutral | C$1.74B | -13.95 | -9.71% | ― | 4.27% | 3.41% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | C$2.63B | -8.05 | -28.58% | ― | -3.38% | -31.35% | |
48 Neutral | C$2.17B | -1.75 | -30.10% | ― | -4.58% | -141.91% | |
45 Neutral | C$623.46M | -3.01 | -33.00% | ― | -6.48% | 22.63% | |
42 Neutral | C$34.86M | -0.41 | -2.21% | ― | -6.05% | ― |
* Healthcare Sector Average
TSE:IAN
iAnthus Capital Holdings
0.01
0.00
0.00%
TSE:CURA
Curaleaf Holdings
3.39
2.36
229.13%
TSE:GTII
Green Thumb Industries
9.87
2.72
38.04%
TSE:TRUL
Trulieve Cannabis
9.06
4.46
96.96%
TSE:CL
Cresco Labs
1.40
0.63
81.82%
TSE:VRNO
Verano Holdings
6.32
0.00
0.00%
iAnthus Capital Holdings Corporate Events
Business Operations and StrategyFinancial Disclosures
iAnthus Revenue and Profit Slide in 2025 as Net Loss Widens
Negative
Mar 27, 2026
iAnthus Capital Holdings, a multi-state cannabis operator with vertically integrated cultivation, processing and retail assets, reported declines in revenue and profitability for fiscal 2025 amid a challenging U.S. cannabis market. The companyR...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.